CROI 2017: With possibilities for long-acting HIV treatment, modern science creates modern ART

By on .

In injections or implants, technology that eliminates daily pill taking, and with it “pill fatigue,” stigma, and other barriers to adherence,  has already proven its value, and is on the horizon for HIV SEATTLE – Surveys indicate that the majority of people living with HIV would be happier with a monthly injection than a daily pill. At […]

Long-acting injectable HIV treatment shows promise in early study results

By on .

A future of HIV treatment that doesn’t depend on daily dosing seemed to move a little closer today with an announcement that early findings show an injected combination of two antiretroviral medicines given monthly or every two months effective in controlling HIV among people whose virus was already suppressed. The findings come from the first […]

ASTMH 2019: In plans to end AIDS impacts on children, an easier trip to the clinic could make all the difference

By on .

NATIONAL HARBOR, MARYLAND – In Malawi, where more than half the population lives in poverty, the available transportation to a clinic can determine whether a child or adolescent living with HIV gets treatment adequate enough to suppress the virus. At the 68th Annual Meeting of the American Association of Tropical Medicine and Hygiene, where aisles […]

IAS 2019: While plans for HIV control innovations accelerate, community input remains an afterthought

By on .

MEXICO CITY – “What HIV has pointed out is that building it does not make them come,” Ambassador Dr. Deborah Birx noted at an opening night press event that highlighted persisting gaps in HIV testing, treatment, prevention access across the globe. When services don’t reach clients and communities, she said, people offering them have to […]

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

By on .

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]

IAS 2017: With resources already stretched, cuts will hurt, global health advocates say

By on .

PARIS – In a year that marks the half-way point to the deadline for ambitious goals to contain and then end the global health impacts of HIV, and when the latest data illustrate the payoff of focused and determined investments, a flat donor landscape has opened a stark view of an alternate reality. Encompassed in […]

HIVR4P 2016: From dapivirine rings to multipurpose prevention tools, “we still have a huge job ahead of us”

By on .

CHICAGO – The last time she visited Africa, Sharon Hillier recounts, she met a local woman who was unimpressed with the work scientists had done so far to protect women living in low-resource settings, exposed to multiple risks. You need to get back to work and make something we can use, Hillier, a microbiologist at the University […]

HIVR4P 2016: Live from Chicago

By on .

CHICAGO – As the quest of new biomedical tools and interventions to prevent HIV infection and illness continues, Science Speaks is in Chicago this week covering the HIV Research For Prevention — HIVR4P 2016 — Conference. The conference promises news of developments in HIV treatment as prevention, pre-exposure prophylaxis, circumcision (or, as they say here, TasP, […]